These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 24579534)

  • 21. Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: a 15-year follow-up of the Chinese Multi-provincial Cohort Study.
    Liu J; Wang W; Wang M; Sun J; Liu J; Li Y; Qi Y; Wu Z; Zhao D
    Diabetes Res Clin Pract; 2012 May; 96(2):217-24. PubMed ID: 22244364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
    He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
    Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ; Lundman P; Tardif JC
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.
    Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle R; Sapkota RM; Sigdel T
    BMC Res Notes; 2017 Apr; 10(1):146. PubMed ID: 28376848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: the di@bet.es study.
    Martinez-Hervas S; Carmena R; Ascaso JF; Real JT; Masana L; Catalá M; Vendrell J; Vázquez JA; Valdés S; Urrutia I; Soriguer F; Serrano-Rios M; Rojo-Martínez G; Pascual-Manich G; Ortega E; Mora-Peces I; Menéndez E; Martínez-Larrad MT; López-Alba A; Gomis R; Goday A; Girbés J; Gaztambide S; Franch J; Delgado E; Castell C; Castaño L; Casamitjana R; Calle-Pascual A; Bordiú E
    Clin Investig Arterioscler; 2014; 26(3):107-14. PubMed ID: 24461346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
    Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
    Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS; Aslam M
    Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.
    Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS
    Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions].
    Gao Y; Zhong XN; Yang YH; Tian KC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):432-5. PubMed ID: 22883098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
    Taskinen MR; Borén J
    Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.